2017 Drug Design and Delivery Symposium
This year is organized to highlight the work being done by chemists to combat some of the diseases that plague us. Register to hear experts detail the work that is being done in oncology, anti-infectives and immunology.
| I - Fighting Cancer | |
|---|---|
| January 26 | Fighting Cancer: Targeting CNS Malignancy with Kinase Inhibitors Timothy P. Heffron - Genentech Mark Wittman - BMS |
| February 23 | Fighting Cancer: Epigenetic targets for Oncology Stuart Conway - Oxford Sharan Bagal - AstraZeneca |
| March 23 | Fighting Cancer: Allostery and Targeting Cancer Cell Metabolism Stefan Gross - Agios Scott Edmundson - AstraZeneca |
| Special Broadcast | |
| April 20 | Cystic Fibrosis: Discovery of CFTR Modulators Peter Grootenhuis - Vertex Nick Meanwell - BMS |
| II - Anti-infectives | |
| May 25 | Anti-Infectives: Rational Approaches to the Design and Optimization Jason Sello - Brown University Courtney Aldrich - University of Minnesota |
| June 29 | Tuberculosis: An Introduction for Medicinal Chemists |
| July 27 | Viral Hepatitis: The Search for a Cure Mike Sofia - Arbutus Biopharma Stephen Mason - CaroGen Corporation |
| Special Broadcast | |
| September 28 | Spinal Muscular Atrophy Kevin Hodgetts - Harvard Medical School Alyson Weidmann - ACS Publications |
| III - Immunology | |
| October 26 | Psoriasis: Treatment and Novel Approaches Frank Narjes - AstraZeneca John Morrison - Bristol-Myers Squibb |
| November 30 | Lupus Laurence Menard - BMS Mary Struthers - BMS |
Content Advisors
Dan Erlanson
Carmot Therapeutics
Mark Wittman
Bristol-Myers Squibb
;void(0);){kind=link}